Saved in:
Bibliographic Details
Main Authors: Wang, Ziheng, Li, Xinhe, Momma, Haruki, Nagatomi, Ryoichi
Format: Preprint
Published: 2024
Subjects:
Online Access:https://arxiv.org/abs/2408.01445
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866914899226001408
author Wang, Ziheng
Li, Xinhe
Momma, Haruki
Nagatomi, Ryoichi
author_facet Wang, Ziheng
Li, Xinhe
Momma, Haruki
Nagatomi, Ryoichi
contents To enhance therapeutic outcomes from a pharmacological perspective, we propose MiranDa, designed for medication recommendation, which is the first actionable model capable of providing the estimated length of stay in hospitals (ELOS) as counterfactual outcomes that guide clinical practice and model training. In detail, MiranDa emulates the educational trajectory of doctors through two gradient-scaling phases shifted by ELOS: an Evidence-based Training Phase that utilizes supervised learning and a Therapeutic Optimization Phase grounds in reinforcement learning within the gradient space, explores optimal medications by perturbations from ELOS. Evaluation of the Medical Information Mart for Intensive Care III dataset and IV dataset, showcased the superior results of our model across five metrics, particularly in reducing the ELOS. Surprisingly, our model provides structural attributes of medication combinations proved in hyperbolic space and advocated "procedure-specific" medication combinations. These findings posit that MiranDa enhanced medication efficacy. Notably, our paradigm can be applied to nearly all medical tasks and those with information to evaluate predicted outcomes. The source code of the MiranDa model is available at https://github.com/azusakou/MiranDa.
format Preprint
id arxiv_https___arxiv_org_abs_2408_01445
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle MiranDa: Mimicking the Learning Processes of Human Doctors to Achieve Causal Inference for Medication Recommendation
Wang, Ziheng
Li, Xinhe
Momma, Haruki
Nagatomi, Ryoichi
Computers and Society
Artificial Intelligence
Machine Learning
To enhance therapeutic outcomes from a pharmacological perspective, we propose MiranDa, designed for medication recommendation, which is the first actionable model capable of providing the estimated length of stay in hospitals (ELOS) as counterfactual outcomes that guide clinical practice and model training. In detail, MiranDa emulates the educational trajectory of doctors through two gradient-scaling phases shifted by ELOS: an Evidence-based Training Phase that utilizes supervised learning and a Therapeutic Optimization Phase grounds in reinforcement learning within the gradient space, explores optimal medications by perturbations from ELOS. Evaluation of the Medical Information Mart for Intensive Care III dataset and IV dataset, showcased the superior results of our model across five metrics, particularly in reducing the ELOS. Surprisingly, our model provides structural attributes of medication combinations proved in hyperbolic space and advocated "procedure-specific" medication combinations. These findings posit that MiranDa enhanced medication efficacy. Notably, our paradigm can be applied to nearly all medical tasks and those with information to evaluate predicted outcomes. The source code of the MiranDa model is available at https://github.com/azusakou/MiranDa.
title MiranDa: Mimicking the Learning Processes of Human Doctors to Achieve Causal Inference for Medication Recommendation
topic Computers and Society
Artificial Intelligence
Machine Learning
url https://arxiv.org/abs/2408.01445